Bispham Barbara Harlin

Track

Insider profile

Bispham Barbara Harlin's trades of Crescent Biopharma, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-16
PlS Planned sale
68,038 +34.9%
273.89
US$1,384,267 		68,038 +34.9% 273.89 US$1,384,267
2026-06-23 2026-06-22
PlS Planned sale
84,259 +10.9%
249.10
US$3,971,601 		84,259 +10.9% 249.10 US$3,971,601